(Q38205451)

31 August 2017

title

LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014. (English)

1 reference

31 August 2017

3

1 reference

31 August 2017

6

Eric Caumes

0 references

Jan Clerinx

7

object named as

Jan Clerinx

1 reference

31 August 2017

10

Christoph Hatz

1 reference

31 August 2017

12

Diana N J Lockwood

1 reference

31 August 2017

Johannes Blum

1

1 reference

31 August 2017

Pierre Buffet

2

1 reference

31 August 2017

Gundel Harms

4

1 reference

31 August 2017

Mark S Bailey

5

1 reference

31 August 2017

Eric Caumes

6

1 reference

31 August 2017

Pieter P A M van Thiel

8

1 reference

31 August 2017

Gloria Morizot

9

1 reference

31 August 2017

Thomas P C Dorlo

11

1 reference

31 August 2017

publication date

1 March 2014

1 reference

Journal of Travel Medicine

31 August 2017

published in

1 reference

31 August 2017

volume

21

1 reference

31 August 2017

issue

2

1 reference

31 August 2017

page(s)

116-129

1 reference

[Diagnosis and therapy of cutaneous and mucocutaneous Leishmaniasis in Germany].

31 August 2017

cites work

1 reference

Treatment of cutaneous leishmaniasis among travellers

21 January 2018

1 reference

New world cutaneous leishmaniasis in travellers

21 January 2018

1 reference

Treatment of cutaneous leishmaniasis in travelers 2009.

21 January 2018

1 reference

New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment.

21 January 2018

1 reference

Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis

21 January 2018

1 reference

Persistence of leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure?

21 January 2018

1 reference

Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis

21 January 2018

1 reference

Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.

21 January 2018

1 reference

Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador

21 January 2018

1 reference

Monitoring toxicity associated with parenteral sodium stibogluconate in the day-case management of returned travellers with New World cutaneous leishmaniasis [corrected]

21 January 2018

1 reference

Electrocardiographic and biochemical adverse effects of sodium stibogluconate during treatment of cutaneous and mucosal leishmaniasis among returned travellers

21 January 2018

1 reference

Thrombocytopenia complicating sodium stibogluconate therapy for cutaneous leishmaniasis

21 January 2018

1 reference

Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis

21 January 2018

1 reference

Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis

21 January 2018

1 reference

Rhabdomyolysis associated with pentamidine isethionate therapy for American cutaneous leishmaniasis

21 January 2018

1 reference

Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guiana

21 January 2018

1 reference

Treatment of New World cutaneous leishmaniasis with miltefosine

21 January 2018

1 reference

Oral miltefosine for the treatment of Indian visceral leishmaniasis

21 January 2018

1 reference

Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis

21 January 2018

1 reference

Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients.

21 January 2018

1 reference

Translational pharmacokinetic modelling and simulation for the assessment of duration of contraceptive use after treatment with miltefosine.

21 January 2018

1 reference

Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis

21 January 2018

1 reference

Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony

21 January 2018

1 reference

Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: A double-blind control study

21 January 2018

1 reference

WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study

21 January 2018

1 reference

Topical paromomycin with or without gentamicin for cutaneous leishmaniasis

21 January 2018

1 reference

Long-term efficacy of single-dose radiofrequency-induced heat therapy vs. intralesional antimonials for cutaneous leishmaniasis in India

21 January 2018

1 reference

Evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Kabul, Afghanistan: a randomized controlled trial

21 January 2018

1 reference

Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate.

21 January 2018

1 reference

A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection

21 January 2018

1 reference

Miltefosine treatment of Leishmania major infection: an observational study involving Dutch military personnel returning from northern Afghanistan

21 January 2018

1 reference

Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran

21 January 2018

1 reference

Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major

21 January 2018

1 reference

Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: a randomized clinical trial.

21 January 2018

1 reference

Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis

21 January 2018

1 reference

Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate

21 January 2018

1 reference

Efficacy of glucantime in the treatment of Old World cutaneous leishmaniasis

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis

21 January 2018

1 reference

Travelers with cutaneous leishmaniasis cured without systemic therapy

21 January 2018

1 reference

Treatment of 'Old World' cutaneous leishmaniasis with aminosidine ointment: results of an open study in London

21 January 2018

1 reference

Treatment of acute Old World cutaneous leishmaniasis: a systematic review of the randomized controlled trials.

21 January 2018

1 reference

Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria.

21 January 2018

1 reference

Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis

21 January 2018

1 reference

Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial

21 January 2018

1 reference

Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica

21 January 2018

1 reference

Cutaneous infection with Leishmania infantum in an infant treated successfully with miltefosine

21 January 2018

1 reference

Resolution of cutaneous old world and new world leishmaniasis after oral miltefosine treatment

21 January 2018

1 reference

Miltefosine to treat cutaneous leishmaniasis caused by Leishmania tropica

21 January 2018

1 reference

Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial

21 January 2018

1 reference

Cutaneous leishmaniasis with lymphadenopathy due to Leishmania donovani

21 January 2018

1 reference

Cutaneous leishmaniasis after travel to Cyprus and successful treatment with miltefosine

21 January 2018

1 reference

Successful treatment of imported mucosal Leishmania infantum leishmaniasis with miltefosine after severe hypokalemia under meglumine antimoniate treatment

21 January 2018

1 reference

Treatment of mucosal leishmaniasis (L. infantum) with miltefosine in a patient with Good syndrome.

21 January 2018

1 reference

Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis

21 January 2018

1 reference

[Diagnosis and therapy of cutaneous and musculocutaneous Leishmaniasis in Germany].

21 January 2018

1 reference

Case report: Successful treatment of cutaneous leishmaniasis caused by Leishmania aethiopica with liposomal amphothericin B in an immunocompromised traveler returning from Eritrea

21 January 2018

1 reference

Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis

21 January 2018

1 reference

Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent

21 January 2018

1 reference

Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children

21 January 2018

1 reference

Miltefosine for new world cutaneous leishmaniasis.

21 January 2018

1 reference

Efficacy of Miltefosine for the Treatment of American Cutaneous Leishmaniasis

21 January 2018

1 reference

Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis

21 January 2018

1 reference

Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam

21 January 2018

1 reference

A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis

21 January 2018

1 reference

Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil

21 January 2018

1 reference

Evaluation of treatment with pentamidine for cutaneous leishmaniasis in Suriname

21 January 2018

1 reference

Placebo-Controlled Clinical Trial of Sodium Stibogluconate (Pentostam) versus Ketoconazole for Treating Cutaneous Leishmaniasis in Guatemala

21 January 2018

1 reference

Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers

21 January 2018

1 reference

Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial

21 January 2018

1 reference

Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study

21 January 2018

1 reference

Mucosal leishmaniasis ("espundia" Escomel, 1911).

21 January 2018

1 reference

Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis.

21 January 2018

1 reference

21 January 2018

1 reference

Randomized, Double‐Blind Study of Stibogluconate Plus Human Granulocyte Macrophage Colony‐Stimulating Factor versus Stibogluconate Alone in the Treatment of Cutaneous Leishmaniasis

21 January 2018

1 reference

Out-patient parenteral antimicrobial therapy--a viable option for the management of cutaneous leishmaniasis

21 January 2018

1 reference

Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis

21 January 2018

1 reference

Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.

21 January 2018

1 reference

Treatment of imported New World cutaneous leishmaniasis in Germany

21 January 2018

1 reference

First cases of cutaneous leishmaniasis caused by Leishmania (Viannia) naiffi infection in Surinam

21 January 2018

1 reference

Spontaneous cure of American cutaneous leishmaniasis due to Leishmania naiffi in two Dutch infantry soldiers

21 January 2018

1 reference

Mucosal Leishmania infantum infection

21 January 2018

1 reference

Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil

21 January 2018

1 reference

Mucosal leishmaniasis . Current scenario and prospects for treatment.

21 January 2018

1 reference

Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis

21 January 2018

1 reference

American cutaneous leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline

21 January 2018

1 reference

Can we use a lower dose of liposomal amphotericin B for the treatment of mucosal American leishmaniasis?

21 January 2018

1 reference

Localized mucosal leishmaniasis due to Leishmania (Leishmania) infantum: clinical and microbiologic findings in 31 patients.

21 January 2018

1 reference

Optimal dosing of miltefosine in children and adults with visceral leishmaniasis

21 January 2018

1 reference

The relationship between leishmaniasis and AIDS: the second 10 years

21 January 2018

1 reference

Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment

21 January 2018

1 reference

Traitement des leishmanioses en France : proposition d’un référentiel consensuel

21 January 2018

1 reference

Comparison between one and two injections of pentamidine isethionate, at 7 mg/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana

21 January 2018

1 reference

Treatment response of cutaneous leishmaniasis due to Leishmania aethiopica to cryotherapy and generic sodium stibogluconate from patients in Silti, Ethiopia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JTM.12089

1 reference

31 August 2017

1 reference